Skip to main content
logo
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.890
-0.200 (-9.57%)
At close: Aug 7, 2026, 4:00 PM EDT
1.830
-0.060 (-3.17%)
After-hours: Aug 7, 2026, 7:59 PM EDT

ZYBT Revenue

In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M CNY, down -37.56%. Zhengye Biotechnology Holding had revenue of 54.03M in the half year ending December 31, 2025, a decrease of -43.00%.

Revenue (ttm)
116.36M CNY
Revenue Growth
-37.56%
P/S Ratio
5.31
Revenue / Employee
432,572 CNY
Employees
269
Market Cap
89.57M USD

Revenue Chart

Chart
* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025116.36M-69.99M-37.56%
Dec 31, 2024186.36M-25.30M-11.95%
Dec 31, 2023211.65M-48.62M-18.68%
Dec 31, 2022260.27M46.20M21.58%
Dec 31, 2021214.07M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Aurora Cannabis221.16M
Organigram Global196.43M
Lifecore Biomedical129.46M
ADC Therapeutics79.18M
Journey Medical64.68M
Cumberland Pharmaceuticals44.30M
BGM Group37.92M
China Pharma Holdings3.99M
Revenue Rankings

ZYBT News

More News